- Home
- GRI vs ITP Comparison
GRI vs ITP Comparison
Compare GRI & ITP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRI
- ITP
- Stock Information
- Founded
- GRI 2018
- ITP 1996
- Country
- GRI United States
- ITP China
- Employees
- GRI N/A
- ITP N/A
- Industry
- GRI Biotechnology: Pharmaceutical Preparations
- ITP Paper
- Sector
- GRI Health Care
- ITP Basic Materials
- Exchange
- GRI Nasdaq
- ITP Nasdaq
- Market Cap
- GRI 3.6M
- ITP 3.6M
- IPO Year
- GRI N/A
- ITP N/A
- Fundamental
- Price
- GRI $1.43
- ITP $0.20
- Analyst Decision
- GRI Strong Buy
- ITP
- Analyst Count
- GRI 2
- ITP 0
- Target Price
- GRI $22.00
- ITP N/A
- AVG Volume (30 Days)
- GRI 84.2K
- ITP 413.3K
- Earning Date
- GRI 08-14-2025
- ITP 08-14-2025
- Dividend Yield
- GRI N/A
- ITP N/A
- EPS Growth
- GRI N/A
- ITP N/A
- EPS
- GRI N/A
- ITP N/A
- Revenue
- GRI N/A
- ITP $78,416,221.00
- Revenue This Year
- GRI N/A
- ITP N/A
- Revenue Next Year
- GRI N/A
- ITP N/A
- P/E Ratio
- GRI N/A
- ITP N/A
- Revenue Growth
- GRI N/A
- ITP 12.26
- 52 Week Low
- GRI $1.10
- ITP $0.15
- 52 Week High
- GRI $30.43
- ITP $1.07
- Technical
- Relative Strength Index (RSI)
- GRI 48.16
- ITP 45.64
- Support Level
- GRI $1.33
- ITP $0.18
- Resistance Level
- GRI $1.45
- ITP $0.22
- Average True Range (ATR)
- GRI 0.09
- ITP 0.02
- MACD
- GRI 0.01
- ITP -0.00
- Stochastic Oscillator
- GRI 53.61
- ITP 38.00
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
About ITP IT Tech Packaging Inc.
IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.